ACTIVATION REGIMENS TO PREPARE BOVINE OOCYTES FOR INTRACYTOPLASMIC SPERM INJECTION

Citation
Gj. Rho et al., ACTIVATION REGIMENS TO PREPARE BOVINE OOCYTES FOR INTRACYTOPLASMIC SPERM INJECTION, Molecular reproduction and development, 50(4), 1998, pp. 485-492
Citations number
50
Categorie Soggetti
Reproductive Biology","Developmental Biology",Biology,"Cell Biology
ISSN journal
1040452X
Volume
50
Issue
4
Year of publication
1998
Pages
485 - 492
Database
ISI
SICI code
1040-452X(1998)50:4<485:ARTPBO>2.0.ZU;2-K
Abstract
Activation of bovine oocytes to produce a single haploid pronucleus in preparation for intracytoplasmic sperm injection (ICSI) has been inve stigated with Various combinations of ionomycin and 6-dimethylaminopur ine (DMAP). Effects were evaluated by immunocytochemical staining, chr omosomal analysis and assessment of development in vitro. Oocytes matu red in vitro were exposed to: ionomycin alone (single or repeated trea tments, Groups 1 and 2 respectively), ionomycin followed by DMAP (imme diately or after a 3-h delay, Groups 3 and 4), or no treatment (contro l, Group 5). They were then co-cultured in M199 with bovine oviductal epithelial cells. Activation rates were not significantly different am ong groups but significantly fewer oocytes in Group 3 extruded a secon d polar body than in Groups 1, 2, and 4. Most parthenotes (60% to 80%) in Groups 1, 2, and 4 were haploid, whereas 82% in Group 3 were mixop loid or polyploid. Most of the parthenotes (88%) in Group 4 formed a s ingle pronucleus besides extruding the second polar body and were ther efore more suitable for ICSI than those of Groups 1 and 2 in which con densed chromosomes predominated. The respective rates of oocyte cleava ge in Groups 1 to 4 were 24%, 36%, 70%, and 75%; corresponding blastoc yst rates were 1%, 5%, 17%, and 8%. There were significantly fewer cel ls in the parthenotes of Groups 1, 2, and 4 than of Group 3, or of emb ryos produced by in vitro fertilization. Thus, delaying the addition o f DMAP after ionomycin decreases chromosomal abnormalities and produce s a high proportion of activated oocytes suitable for ICSI. Mol. Repro d. Dev. 50:485-492, 1998. (C) 1998 Wiley-Liss, Inc.